FDA Inspection 1052431 — Rising Pharma Holdings, Inc
The FDA completed an inspection of Rising Pharma Holdings, Inc on May 16, 2018 in Decatur, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 16, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Decatur, IL (United States)